SCHEMBL2869240

SCHEMBL2869240

CCCCCOc1ccc(NC(=S)NC(=O)c2cccnc2N(C)C)cc1C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.50
ALDH1A1 P00352 6/20 0.43
HTT P42858 2/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
SIRT1 Q96EB6 1/20 0.42
NPSR1 Q6W5P4 3/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
ALOX12 P18054 2/20 0.40
MAPK1 P28482 1/20 0.40
CCR6 P51684 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
PAX8 Q06710 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2868160 0.89 S1PR1 (0.50) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2863994 0.89 S1PR1 (0.50) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2862531 0.88 S1PR1 (0.47) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2865604 0.88 S1PR1 (0.49) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2860051 0.88 THRA (0.47) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2861296 0.87 S1PR1 (0.49) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2862658 0.86 S1PR1 (0.48) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2860251 0.86 S1PR1 (0.49) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL2866607 0.84 S1PR1 (0.48) S1PR1ALDH1A1HTTTHRATHRB
SCHEMBL14096277 0.84 MEN1 (0.50) S1PR1ALDH1A1HTTNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101087755-A Substituted arylacylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS INC (US) 2007-12-12 CN claimed
EP-1747196-A2 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION Achillion Pharmaceuticals, Inc. (US) 2007-01-31 EP claimed
WO-2006083271-A2 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2006-08-10 WO claimed
US-20060025416-A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2006-02-02 US claimed
US-7767706-B2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2010-08-03 US disclosed
US-20090023730-A1 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS (US) 2009-01-22 US disclosed
US-20060025416-A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025416-A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication PIGS, NAT1, AADAC S1PR1 1409/4885ALDH1A1 176/4885HTT 1526/4885
US-20090023730-A1 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION PIGS, NAT1, AADAC S1PR1 1409/4885ALDH1A1 176/4885HTT 1526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.